Sitka Biopharma is a preclinical biotechnology company dedicated to advancing its innovative nanoparticle platform technology, which enhances the absorption of drugs in challenging tissues. By improving drug delivery, Sitka Biopharma aims to revolutionize treatment options for conditions that require effective penetration into hard-to-reach areas.